Overview

Olanzapine/Fluoxetine Combination Versus Comparator in the Treatment of Bipolar I Depression

Status:
Completed
Trial end date:
2005-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess olanzapine/fluoxetine combination and lamotrigine comparative efficacy, safety and tolerability in acute and longer term treatment of bipolar depression.
Phase:
Phase 4
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Fluoxetine
Lamotrigine
Olanzapine